Diagnosis and follow up of aortitis in the elderly.
OBJECTIVE
To evaluate the correlation of MRI and [(18)F]FDG-PET scans with the clinical course and inflammatory markers in patients with aortitis.


METHODS
Eight patients with aortitis presenting with unspecific GCA-like symptoms were examined. Aortitis was diagnosed and followed up by [(18)F]FDG-PET and MRI. The aorta was divided into three vascular regions (ascending aorta, aortic arch, and descending aorta) to localise the aortic inflammation and compare both imaging techniques.


RESULTS
were correlated with clinical and laboratory examinations.


RESULTS
At diagnosis, 20/24 vascular regions from eight patients were positive by [(18)F]FDG-PET scan and 15/21 aortic regions by MRI. Patients were treated with corticosteroids and followed up for a mean (SD) of 13.3 (4.7) months. In [(18)F]FDG-PET, 11/20 (55%) initially pathological aortic regions returned to normal in the follow up examination, which correlated closely with the clinical and laboratory follow up examination. Conversely, in MRI, 14/15 initially affected vascular regions were unchanged.


CONCLUSIONS
[(18)F]FDG-PET and MRI are both effective techniques for detecting early aortitis and have a high correlation with laboratory inflammatory measures. However, during the follow up examination, [(18)F]FDG-PET uptake decreased in line with the clinical symptoms and inflammatory serum markers, whereas MRI scans gave more static results.
Scheel
A K
AK
Department of Medicine, Georg-August-University Göttingen, D-37075 Göttingen, Germany. ascheel@gwdg.de
Meller
J
J
Vosshenrich
R
R
Kohlhoff
E
E
Siefker
U
U
Müller
G A
GA
Strutz
F
F
D000368:Aged; D001011:Aorta / Q000000981:diagnostic imaging / Q000473:pathology; D001025:Aortitis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy*; D015415:Biomarkers / Q000097:blood; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography; D011237:Predictive Value of Tests; D012189:Retrospective Studies
D015415:Biomarkers; D007166:Immunosuppressive Agents; D002097:C-Reactive Protein